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Abstract	  
	  
OBJECTIVES:	   We	   sought	   to	   explore	   the	   safety	   and	   prognostic	   accuracy	   of	   low-­‐dose	  dobutamine	  stress	  echocardiography	  (DSE),	  performed	  early	  in	  the	  course	  of	  acute	  anterior	  ST	  elevation	  myocardial	  infarction	  (STEMI),	  in	  patients	  who	  received	  thrombolytic	  therapy.	  
METHODS:	  We	   enrolled	  73	   consecutive	  patients	  presenting	  with	   first	   acute	   anterior	   STEMI,	  who	   had	   significant	   coronary	   stenosis/occlusion	   of	   the	   culprit	   artery	   amenable	   for	  revascularization.	   Low-­‐dose	   DSE	   was	   performed	   within	   2-­‐7	   (3.8±1.8)	   days	   of	   the	   index	  hospitalization.	   Patients	   underwent	   coronary	   revascularization.	   Follow-­‐up	   echocardiography	  was	  carried	  out	  2-­‐3	  months	  after	  revascularization	  to	  assess	  regional	  wall	  motion	  abnormality.	  Predicted	  viability	  by	  low-­‐dose	  DSE	  was	  compared	  with	  actual	  contractility	  improvement	  seen	  at	  follow-­‐up	  echocardiography.	  	  
RESULTS:	   Considering	   a	   per-­‐patient	   analysis,	   low-­‐dose	   DSE	   early	   after	   anterior	   STEMI	  predicted	  viability	  with	  a	  sensitivity	  of	  88.9%,	  specificity	  of	  75.7%,	  PPV	  of	  78%,	  NPV	  of	  87.5%.	  Built	   on	   a	   per-­‐segment	   analysis,	   low-­‐dose	  DSE	   achieved	   a	   sensitivity	   of	   86.9%,	   specificity	   of	  92.5%,	  PPV	  of	  73.2%,	  NPV	  of	  96.8%.	  Based	  on	  a	  per-­‐segment	  analysis	  performed	  individually	  for	   hypokinetic	   segments,	   low-­‐dose	   DSE	   achieved	   a	   sensitivity	   of	   88%,	   specificity	   of	   85.4%,	  PPV	   of	   74%,	   NPV	   of	   93.8%.	   For	   akinetic	   segments,	   low-­‐dose	   DSE	   achieved	   a	   sensitivity	   of	  82.4%,	  specificity	  of	  97%,	  PPV	  of	  70%,	  NPV	  of	  98.5%.	  
CONCLUSION:	   Low-­‐dose	   DSE	   performed	   early	   in	   patients	   presenting	   with	   acute	   anterior	  STEMI	   who	   received	   thrombolytic	   therapy,	   is	   safe	   with	   a	   high	   sensitivity	   but	   a	   modest	  specificity	   for	   predicting	   contractile	   improvement	   after	   revascularization,	   based	   on	   a	   per-­‐patient	  analysis.	  However,	  based	  on	  a	  per-­‐segment	  analysis,	  both	  sensitivity	  and	  specificity	  are	  high.	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INTRODUCTION	  	  Identification	   of	   viable	   myocardium	   after	  myocardial	   infarction	   (MI)	   has	   gained	  paramount	   importance	   with	   the	   latest	  progress	   in	   myocardial	   revascularization	  over	   the	   past	   two	   decades,	   especially	   in	  
patients	   scheduled	   for	   coronary	  intervention	   [1].	   Myocardial	   viability	  represents	   transient	   impairment	   of	  contractility	   with	   potential	   recovery	   when	  blood	   supply	   is	   restored	   [2].	   Improving	  blood	  supply	  to	  viable	  myocardial	  segments	  following	  MI	  results	  in	  improvement	  of	   left	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ventricular	   contractility,	   clinical	   heart	  failure,	   functional	   capacity,	   and	   reduces	  long-­‐term	   mortality.	   Therefore,	   an	  important	   concern	   is	   whether	   hypokinetic	  or	   akinetic	   myocardial	   segments	   following	  MI	   represent	   viable	   myocardium	   -­‐	   with	  severely	   reduced	   blood	   supply	   -­‐or	  permanently	   damaged	   scar	   tissue	   [3].	   This	  theme	   was	   supported	   by	   the	   results	   of	   a	  prior	   report,	   in	   which	   only	   those	   with	  severe	   left	   ventricular	   systolic	   dysfunction	  after	  MI	  -­‐	  who	  harbored	  viable	  myocardium	  -­‐	   improved	   by	   coronary	   revascularization	  [4].	  	  	   Pharmacological	   stress	  echocardiography	   is	   widely	   acknowledged	  for	   the	   identification	  of	  viable	  myocardium	  in	   post-­‐MI	   patients,	   chiefly	   because	   it	   is	  feasible,	   safe,	   with	   a	   high	   diagnostic	   and	  prognostic	   accuracy	   [5].	   Low-­‐dose	  dobutamine	  stress	  echocardiography	  (DSE)	  has	   emerged	   as	   an	   appealing	   tool	   for	  identifying	   viable	   myocardium	   through	   its	  ability	   to	   elicit	   a	   beta	   receptor-­‐mediated	  increase	   in	   myocardial	   thickening.	   Low-­‐dose	   dobutamine	   response	   accurately	  predicts	  potential	  recovery	  of	  dysfunctional	  -­‐	   yet	   viable	   -­‐	   myocardial	   regions	   and	   thus	  identifying	   a	   subset	   of	   patients	   whose	   left	  ventricular	   function	  will	   improve	   following	  successful	   coronary	   revascularization	   [6].	  The	   problem	   of	   inter-­‐	   and	   intra-­‐observer	  variability	   can	   be	   minimized	   by	   stronger	  adherence	   to	   common	   and	   new	  methodological	  standards	  [7].	  Dobutamine-­‐responsive	   wall	   motion	   is	   specific	   for	  predicting	   reversible	   impairment	   of	  contractility;	   yet,	   its	   sensitivity	   remains	  suboptimal	   [8].	   In	   a	   prospective	   study,	  we	  sought	  to	  explore	  the	  safety	  and	  prognostic	  accuracy	  of	   low-­‐dose	  DSE,	  performed	  early	  in	  the	  course	  of	  acute	  anterior	  ST	  elevation	  MI	   (STEMI),	   in	   patients	   who	   received	  thrombolytic	  therapy.	  
	  
METHODS	  	  Patient	   selection	   and	   study	   design:	   we	  enrolled	   73	   consecutive	   patients	   admitted	  
to	   our	   intensive	   care	   unit	   with	   first	   acute	  anterior	   STEMI,	   during	   the	   period	   from	  April	   2012	   to	   April	   2013.	   Patients	   were	  considered	  eligible	  for	  inclusion	  if	  they	  had	  received	   thrombolytic	   therapy,	   had	  significant	  stenosis/occlusion	  of	   the	  culprit	  artery,	   and	   a	   culprit	   artery	   amenable	   for	  revascularization	   as	   evident	   from	  subsequent	   coronary	   angiography.	  Significant	   coronary	   stenosis	   was	   defined	  as	   at	   least	   70%	   luminal	   obstruction	   of	   a	  sizable	  arterial	  segment	  (measuring	  2.5	  mm	  or	   more	   in	   diameter),	   seen	   in	   2	   different	  projections.	   Total	   coronary	   occlusion	   was	  defined	   as	   100%	   luminal	   obstruction	  with	  Thrombolysis	   in	   Myocardial	   Infarction	  (TIMI)	   grade	   0	   forward	   flow	   distal	   to	   the	  site	  of	  obstruction.	  The	  diagnosis	  of	  STEMI	  was	   based	   on	   12-­‐lead	   electrocardiogram	  showing	   ST	   segment	   elevation	   of	   1	  mm	  or	  more	   in	   at	   least	   two	   contiguous	   leads	  plus	  one	   of	   the	   following:	   1)	   prolonged	   chest	  discomfort	   typical	   of	   myocardial	   ischemia,	  2)	   elevated	   cardiac	   biomarkers:	   creatine	  kinase-­‐MB	   fraction	   and/or	   troponin	   more	  than	   twice	   the	   upper	   reference	   limit.	   We	  excluded	  patients	  with	  early	  post-­‐MI	  angina	  or	   hemodynamic	   instability,	   congestive	  heart	   failure,	   protruding	   fresh	   left	  ventricular	   thrombus,	   significant	   valvular	  or	  congenital	  heart	  disease,	  any	  myocardial	  disease	   apart	   from	   ischemia,	  contraindication	   to	   dobutamine	   (such	   as	  history	  of	  complex	  ventricular	  arrhythmias,	  uncontrolled	   hypertension	   with	   blood	  pressure	   >180/110),	   and	   patients	   with	  limited	   life	   expectancy	   due	   to	   coexistent	  disease	   (such	   as	   malignancy).	   All	   patients	  received	   fibrinolytic	   therapy	   in	   the	   form	  of	  streptokinase	  given	  at	  a	  dose	  of	  1	  500	  000	  U,	   administrated	   by	   intravenous	   infusion	  for	  30-­‐60	  minutes,	  started	  within	  6	  hours	  of	  the	   onset	   of	   chest	   pain.	   	   Before	   inclusion,	  informed	   written	   consent	   was	   obtained	  from	   each	   patient	   after	   full	   explanation	   of	  the	   study	   protocol,	   and	   the	   protocol	   was	  reviewed	   and	   approved	   by	   the	   our	  institutional	   Human	   Research	   Committee,	  as	   it	   conforms	   to	   the	   ethical	   guidelines	   of	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the	  1964	  Declaration	  of	  Helsinki,	  as	  revised	  in	  2013.	  Baseline	   echocardiographic	  assessment	   of	   regional	   and	   global	   left	  ventricular	  systolic	  function	  was	  performed	  in	   all	   patients	   by	   trans-­‐thoracic	  echocardiography	   within	   48	   hours	   of	  admission.	   Doppler	   echocardiography	   was	  performed	  using	   a	  General	  Electric	  Vivid	  7	  Pro	   cardiac	   ultrasound	   machine	   (General	  Electric,	   Horten,	   Norway)	   equipped	   with	  harmonic	   imaging	   capabilities.	   A	   2.5	   MHz	  phased	   array	   probe	   was	   used	   to	   obtain	  standard	  2-­‐D,	  M-­‐mode	  and	  Doppler	  images.	  Patients	   were	   examined	   in	   the	   left	   lateral	  recumbent	   position	   using	   standard	  parasternal	   and	   apical	   views.	   Images	  were	  digitized	   in	   cine-­‐loop	   format	  and	  saved	   for	  subsequent	   playback	   and	   analysis.	   Views	  were	   analyzed	   by	   a	   single	   observer	   (W.	  Adel)	   employing	   the	   software	   program	   of	  the	   echocardiography	   machine.	   Global	   left	  ventricular	   systolic	   function	   was	   assessed	  in	  apical	  4-­‐chamber	  view	  using	  the	  biplane	  modified	   Simpson’s	   method.	   Regional	   wall	  motion	   was	   assessed	   according	   to	   the	  standard	  16-­‐segment	  model	   recommended	  by	   the	   American	   Society	   of	  Echocardiography	   [9].	   Individual	   segments	  were	   then	   sub	   grouped,	   based	   on	   the	  known	   vascular	   distribution,	   into	   left	  anterior	   descending	   territory,	   left	  circumflex	   territory,	   right	   coronary	   artery	  territory,	   and	   overlap	   segments	   [9].	  Regional	  wall	  motion	  was	  visually	  assessed	  for	   each	   segment	   individually,	   considering	  both	   endocardial	   excursion	   and	   systolic	  thickening,	   and	   each	   segment	   was	   graded	  according	   to	   the	   semi	   quantitative	   scoring	  system	   described	   by	   Knudsen	   and	  associates	   [10].	   Segments	   with	   poorly	  defined	   endocardial	   borders	   for	   50%	   or	  more	  of	   their	   length	  were	   considered	  non-­‐visualized	   and	   assigned	   a	   score	   of	   0	   [11].	  Wall	   thickening	  was	  assessed	  at	  a	  distance	  of	  at	   least	  1	  cm	  from	  the	  adjacent	  segment	  in	  order	  to	  minimize	  the	  effect	  of	  tethering	  [12].	   Wall	   motion	   in	   a	   vascular	   territory	  was	  considered	  abnormal	  if	  wall	  thickening	  
was	   abnormal	   in	   at	   least	   two	   contiguous	  non-­‐overlap	  segments	  [9].	  Dividing	  the	  sum	  of	  individual	  segment	  scores	  by	  the	  number	  of	   interpretable	   segments	   derived	   wall	  motion	  score	  index.	  	  Low-­‐dose	  DSE	  Protocol:	  Dobutamine	  (Dobutrex®,	   Lilly,	   Eli	   and	   Company,	  Indianapolis,	  USA)	  was	  infused	  starting	  at	  5	  microgram/kg/min;	   the	   infusion	   rate	   was	  subsequently	   increased	   by	   5	  microgram/kg/min	  every	  3	  minutes	  (that	  is	  at	  10,	  15	  and	  20	  microgram/kg/min)	  up	  to	  a	   maximal	   infusion	   rate	   of	   20	  microgram/kg/min.	   Standard	   views	   were	  recorded	   at	   baseline,	   during	   each	   stage	   of	  the	   infusion	   protocol,	   as	   well	   as	   during	  recovery.	   The	   same	   observer	   performed	  visual	   assessment	   of	   wall	   motion	   and	  thickening.	   Global	   left	   ventricular	   systolic	  function	  and	  wall	  motion	  score	   index	  were	  evaluated	   at	   rest	   and	   at	   the	   end	   of	   each	  stage.	  The	  presence	  of	  viability	  was	  defined	  by	   improvement	   of	   regional	   wall	   motion	  score	   by	   at	   least	   one	   grade	   in	   at	   least	   two	  contiguous	   non-­‐overlap	   segments	   along	  with	   at	   least	   20%	   reduction	   in	   global	  wall	  motion	   score	   index,	   compared	   with	  baseline	   evaluation	   [12].	   Low-­‐dose	   DSE	  protocol	   was	   performed	   with	   the	   patients	  on	  their	  full	  anti-­‐ischemic	  medications.	  Monitoring:	   All	   patients	   had	  continuous	   heart	   rate,	   ECG,	   and	   pulse	  oxymetry	  monitoring.	  Heart	  rate	  and	  blood	  pressure	   readings	   were	   recorded	   at	  baseline,	   at	   the	   end	   of	   each	   stage	   of	  dobutamine	   infusion,	   and	   during	   the	  recovery	   phase.	   A	   12-­‐lead	   ECG	   was	  recorded	   at	   baseline	   and	   during	   recovery.	  Patients	  were	  questioned	  at	   the	  end	  of	   the	  test	   for	   any	   symptoms	   or	   adverse	   drug	  reactions.	  Coronary	   revascularization:	   All	  patients	   underwent	   culprit	   artery	  revascularization	   within	   2	   weeks	   of	  hospital	  admission,	  by	  either	  percutaneous	  coronary	   angioplasty,	   or	   surgical	   bypass	  grafting,	   according	   to	   the	   operator’s	  discretion.	   Operator’s	   decision	   was	   based	  on	   the	   clinical	   presentation,	   and	   coronary	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anatomy,	   but	   not	   on	   the	   presence	   or	  absence	  of	  viability	  by	  low-­‐dose	  DSE.	  	  Follow-­‐up	   echocardiographic	   re-­‐assessment	   was	   performed	   (by	   the	   same	  observer)	   2-­‐3	   months	   after	  revascularization	   to	   evaluate	   regional	   and	  global	   left	   ventricular	   systolic	   function,	   as	  described	   before.	   The	   presence	   of	  myocardial	   contractile	   improvement	   was	  defined	   by	   improvement	   of	   regional	   wall	  motion	   score	   by	   at	   least	   one	   grade	   in	   at	  least	  two	  contiguous	  non-­‐overlap	  segments	  along	  with	  at	  least	  20%	  reduction	  in	  global	  wall	   motion	   score	   index,	   compared	   with	  baseline	   evaluation.	   During	   follow-­‐up,	  patients	   were	   interrogated	   for	   the	  occurrence	   of	   new	   MI	   or	   congestive	   heart	  failure	   by	   clinical	   visits,	   telephone	   calls,	  hospital	   chart	   reviews,	   or	   personal	  communication	   with	   the	   referring	  physician.	  	  
Statistical	   Analysis:	   Continuous	  variables	   were	   presented	   as	   mean	   +SD,	   if	  they	  were	  normally	   distributed.	  Data	  were	  tested	   for	   normal	   distribution	   using	   the	  Kolmogorov-­‐Smirnov	   test.	   Categorical	  variables	  were	  described	  with	  absolute	  and	  relative	   (percentage)	   frequencies.	   The	  sensitivity,	  specificity,	  positive	  and	  negative	  predictive	   values	   and	   diagnostic	   accuracy	  were	   calculated	   according	   to	   the	   standard	  definitions	   for	   low-­‐dose	   DSE	   protocol	   to	  predict	   viability	   (actual	   contractility	  improvement	   after	   revascularization).	   The	  accuracy	  parameters	  were	  calculated	  based	  on	   a	   per-­‐patient	   analysis,	   then	   based	   on	   a	  per-­‐segment	   analysis	   for	   all	   dys-­‐synergic	  segments.	   Segments	   were	   then	   subdivided	  according	   to	   the	   severity	   of	   baseline	   dys-­‐synergy	   into	   3	   subgroups,	   namely,	  hypokinetic,	   akinetic,	   and	   dyskinetic.	   The	  accuracy	   parameters	   were	   then	   calculated	  individually	  for	  each	  subgroup	  of	  segments	  based	   on	   a	   per-­‐segment	   analysis.	   A	  probability	  value	  of	  p	  <0.05	  was	  considered	  statistically	   significant.	   Analyses	   were	  performed	   with	   SPSS	   version	   16.0	  statistical	   package	   (SPSS	   Inc.,	   Chicago,	   IL,	  USA).	  	  	  
	  
RESULTS	  
	  A	  total	  of	  73	  consecutive	  patients	  with	  first	  acute	   anterior	   STEMI	  were	   enrolled	   in	   the	  current	   study,	   and	   underwent	  revascularization	   of	   the	   culprit	   artery.	  Baseline	   clinical	   and	   echocardiographic	  characteristics	   are	   presented	   in	   table	   1.	  Mean	  age	  was	  49.8	  ±	  10.3	  years	  and	  85%	  of	  patients	   were	   males.	   Low-­‐dose	   DSE	   was	  performed	   within	   2-­‐7	   (3.8±1.8)	   days	   from	  the	   index	   hospitalization.	   Low-­‐dose	   DSE	  protocol	  was	  well	   tolerated	  by	  all	  patients,	  with	   no	   major	   side	   effects	   during	   or	  immediately	   after	   the	   test.	   All	   patients	  completed	  2-­‐3	  months	  of	  follow-­‐up,	  and	  no	  patient	   reported	  any	   clinical	   events	  during	  the	  period	  from	  revascularization	  to	  follow-­‐up	  echocardiography	  evaluation.	  	  Table	   1:	   Baseline	   clinical	   and	  echocardiographic	  characteristics	  
	   Study	  Cohort	  (N=73)	  
Age	  (years)	   49.8	  ±	  10.3	  
Male	  gender	   62	  (84.9)	  
Smoking	   45	  (61.6)	  
Diabetes	   37	  (50.7)	  
Hypertension	   38	  (52.1)	  
Dyslipidemia	   43	  (58.9)	  
FH	  of	  IHD	   27	  (36.9)	  
Medications	   	  
Aspirin	   71	  (97.3)	  
Beta	  blockers	   48	  (65.8)	  
ACE	  inhibitors	   54	  (73.9)	  
Calcium	  antagonists	   23	  (31.5)	  
Diuretics	   31	  (42.5)	  
Echocardiographic	  data	   	  
LV	  EF	  (%)	   41.2	  ±	  8.7	  
WMSI	   1.94	  ±	  0.5	  
Mitral	  regurgitation	   16	  (21.9)	  
Variables	  are	  presented	  as	  mean	  +	  SD	  or	  numbers	  (%),	  
as	  indicated.	  N	  =	  number	  of	  patients,	  ACE	  =	  angiotensin	  
converting	  enzyme,	  FH	  =	  family	  history,	  IHD	  =	  ischemic	  
heart	  disease,	  LV	  EF	  =	  left	  ventricular	  ejection	  fraction,	  
WMSI	  =	  wall	  motion	  score	  index.	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Per-­‐patient	   analysis:	   Of	   73	  patients,	   41	   (56.2%)	   had	   a	   low-­‐dose	   DSE	  positive	  for	  viability	  (of	  whom	  32	  improved	  after	   revascularization	   on	   subsequent	  follow-­‐up	   echocardiography),	   whereas	   32	  (43.8%)	   had	   low-­‐dose	   DSE	   negative	   for	  viability	   (of	   whom	   4	   improved	   after	  revascularization).	   Considering	   a	   per-­‐patient	   analysis,	   low-­‐dose	   DSE	   predicted	  viability	   (contractility	   improvement	   after	  revascularization)	   with	   a	   sensitivity	   of	  88.9%,	   specificity	   of	   75.7%,	   positive	  predictive	  value	  of	  78%,	  negative	  predictive	  value	  of	  87.5%,	  and	  a	  diagnostic	  accuracy	  of	  82.2%.	  	  
Per-­‐segment	   analysis	   for	   all	   dys-­‐
synergic	   segments:	   A	   total	   of	   1168	  segments	  were	   analyzed	   in	   73	   patients.	   Of	  the	  total,	  923	  (79%)	  were	  assigned	  as	  dys-­‐synergic	  at	  baseline	  echocardiography.	  Dys-­‐synergic	   segments	   included	   443	   (48%)	  hypokinetic,	   438	   (47.5%)	   akinetic,	   and	   42	  (4.6%)	  dyskinetic	  segments.	  Of	  the	  923	  dys-­‐synergic	  segments,	  209	  were	  responsive	  to	  low-­‐dose	  DSE	  (of	  which	  153	  improved	  after	  revascularization),	  whereas	  714	  were	  non-­‐responsive	   to	   low-­‐dose	   DSE	   (of	   which	   23	  improved	   after	   revascularization).	  Considering	   a	   per-­‐segment	   analysis,	   low-­‐dose	   DSE	   predicted	   viability	   with	   a	  sensitivity	   of	   86.9%,	   specificity	   of	   92.5%,	  positive	  predictive	  value	  of	  73.2%,	  negative	  predictive	  value	  of	  96.8%,	  and	  a	  diagnostic	  accuracy	  of	  91.4%.	  	  
Per-­‐segment	   analysis	   for	  
individual	  dys-­‐synergic	   segments:	  Of	  the	  443	   hypokinetic	   segments,	   169	   were	  responsive	   to	   low-­‐dose	  DSE	   (of	  which	  125	  improved	  after	  revascularization),	  whereas	  274	  were	   non-­‐responsive	   to	   low-­‐dose	  DSE	  (of	   which	   17	   improved	   after	  revascularization).	   Per-­‐segment	   analysis	  performed	   individually	   for	   hypokinetic	  segments	   revealed	   that	   low-­‐dose	   DSE	  predicted	  viability	   in	  hypokinetic	  segments	  with	   a	   sensitivity	   of	   88%,	   specificity	   of	  85.4%,	   positive	   predictive	   value	   of	   74%,	  negative	   predictive	   value	   of	   93.8%,	   and	   a	  diagnostic	   accuracy	   of	   86.2%.	   Of	   the	   438	  
akinetic	   segments,	   40	   were	   responsive	   to	  low-­‐dose	  DSE	   (of	  which	  28	   improved	  after	  revascularization),	   while	   398	   were	   non-­‐responsive	   to	   low-­‐dose	   DSE	   (of	   which	   6	  improved	   after	   revascularization).	   Per-­‐segment	   analysis	   performed	   individually	  for	   akinetic	   segments	   revealed	   that	   low-­‐dose	   DSE	   predicted	   viability	   in	   akinetic	  segments	   with	   a	   sensitivity	   of	   82.4%,	  specificity	  of	  97%,	  positive	  predictive	  value	  of	  70%,	  negative	  predictive	  value	  of	  98.5%,	  and	   a	   diagnostic	   accuracy	   of	   95.9%.	  All	   42	  dyskinetic	   segments	   were	   non-­‐responsive	  to	   low-­‐dose	   DSE	   (none	   improved	   after	  revascularization).	  	  
DISCUSSION	  
	  The	   results	   of	   the	   current	   study	   suggest	  that	  low-­‐dose	  DSE	  performed	  early	  (within	  2	   to	   7	   days)	   in	   patients	   presenting	   with	  acute	   anterior	   STEMI	   who	   received	  thrombolytic	   therapy,	   is	   safe	  with	   a	   rather	  high	   sensitivity	   (88.9%)	   but	   a	   modest	  specificity	   (75.7%)	   to	  predict	   the	  presence	  of	  myocardial	  viability,	  as	  compared	   to	   the	  'reference	   standard'	   of	   actual	   contractility	  improvement	  after	  revascularization;	  based	  on	  per-­‐patient	  analysis.	  On	  the	  other	  hand,	  based	   on	   per-­‐segment	   analysis,	   specificity	  was	  high	  (92.5%)	  and	  sensitivity	  remained	  almost	   equally	   high	   (86.9%).	   Furthermore,	  prediction	   of	   contractile	   improvement	   in	  akinetic	   segments	   by	   low-­‐dose	   DSE	   was	  highly	   specific	   (97%)	   but	   moderately	  sensitive	   (82.4%),	   whereas	   in	   hypokinetic	  segments,	   it	   was	   less	   specific	   (85.4%)	   but	  more	  sensitive	  (88%).	  The	   finding	   that	   hypokinetic	  segments	   are	   more	   likely	   to	   manifest	  contractile	   improvement	   in	   response	   to	  low-­‐dose	   DSE	   is	   consistent	   with	  histopathology	   studies	   showing	   that	   these	  segments	   harbor	   a	   mixture	   of	   scar	   tissue,	  normal	   and	   hibernating	   myocardium	   in	  variable	   proportions,	   where	   fibrosis	   is	  usually	  minimal	  and	  myocardial	  viability	   is	  more	   common	   [13].	   Nevertheless,	   some	  hypokinetic	   segments	   that	   improved	   with	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low-­‐dose	   DSE	   did	   not	   recover	   contractile	  function	   following	   revascularization.	   This	  coincides	   with	   the	   hypothesis	   that	  hypokinetic	   segments	   may	   not	   always	  represent	   hibernating	   myocardium,	   but	  instead,	   they	  might	   be	   the	   result	   of	   a	   non-­‐transmural	   infarction	   leaving	   a	  heterogeneous	   mixture	   of	   necrotic	   and	  functioning	   myocardium	   (already	   well	  perfused),	   that	   would	   not	   further	   improve	  its	   contractility	   after	   revascularization.	  Alternatively,	   hypokinetic	   segments	   may	  represent	   tethering	   of	   a	   severely	  dysfunctional	   region	   by	   an	   adjacent	  functioning	   segment	   [14].	   These	   factors	  would	   contribute	   to	   a	   higher	   false	  positive	  response	   rate,	   and	   consequently,	   a	   lower	  specificity	   for	   predicting	   functional	  recovery	  in	  hypokinetic	  segments	  following	  revascularization.	  	  In	   contrast,	   low-­‐dose	   DSE	  demonstrated	  a	  lower	  sensitivity	  to	  predict	  viability	   in	   akinetic	   segments.	   This	   can	   be	  attributed	   to	   the	   finding	   that	   these	  segments	   are	   mostly	   supplied	   by	   critically	  stenosed	   or	   totally	   occluded	   coronaries	  with	   so	   exhausted	   coronary	   flow	   reserve,	  that	   even	   at	   low	   levels	   of	   pharmacological	  stress	   they	   fail	   to	   improve	   their	  contractility,	  despite	  the	  presence	  of	  viable	  myocardium	  that	  would	  eventually	  improve	  its	  contractility	  after	  revascularization	  [15].	  Furthermore,	   prediction	   of	   reversible	  contractile	   dysfunction	   in	   akinetic	  segments	   might	   be	   difficult	   with	   the	  standard	  dosage	  of	  low-­‐dose	  DSE,	  owing	  to	  the	  usual	  presence	  of	  a	   large	  infarct	  size	  in	  these	  regions	  [16,17].	  Few	   previous	   studies	   segregated	  myocardial	   segments	   according	   to	   the	  severity	   of	   their	   baseline	   dys-­‐synergy	  (hypokinesia,	  akinesia	  or	  dyskinesia)	  when	  reporting	  the	  prognostic	  power	  of	  low-­‐dose	  DSE	   to	   predict	   contractile	   improvement	  after	   revascularization.	   Ongoing	   with	   our	  results,	   many	   reported	   that	   low-­‐dose	   DSE	  exhibits	   a	   higher	   sensitivity	   and	   lower	  specificity	   for	   predicting	   functional	  recovery	   after	   revascularization	   in	  
hypokinetic	   segments	   as	   compared	   with	  akinetic	  ones	  [17-­‐21].	  Our	  results	  showed	  a	  modest	   sensitivity	   for	   low-­‐dose	   DSE	   for	  predicting	   contractile	   improvement	   after	  revascularization	   of	   akinetic	   segments	  (82.4%).	   Many	   previous	   reports	   observed	  an	   even	   'worse'	   sensitivity	   (range	   from	  11%	   to	   47%)	   for	   predicting	   contractile	  improvement	   in	   akinetic	   segments	  by	   low-­‐dose	   DSE	   [15,17,	   22-­‐24].	   This	   wide	  divergence	   may	   be	   due	   to	   variations	   of	  baseline	   clinical	   characteristics,	   selection	  bias,	   several	   echocardiographic	   and	  angiographic	  technical	  factors,	  and	  different	  timing	   of	   revascularization	   and	  echocardiographic	   reassessment	   following	  revascularization.	  Several	   diagnostic	   imaging	  modalities	   are	   well	   established	   for	  myocardial	   viability	   assessment;	   they	   are	  based	   on	   myocardial	   perfusion	   imaging.	  Single	   Photon	   Emission	   Computed	  Tomography	   (SPECT)	   has	   a	   higher	  sensitivity	   and	   lower	   specificity	   than	  diagnostic	   modalities	   that	   depend	   on	  residual	   contractile	   recovery	   [25].	   Its	  main	  limitations	   include	   significant	   exposure	   to	  ionizing	   radiation,	   low	   spatial	   resolution,	  and	  attenuation	  artifacts.	  Positron	  Emission	  Tomography	   (PET)	   has	   superior	   spatial	  resolution	   and	   attenuation	   correction,	  compared	   with	   SPECT,	   and	   is	   currently	  considered	   the	   gold	   standard	   for	   viability	  assessment.	   It	   is	   limited	  mainly	   by	   lack	   of	  availability	  [26].	  	  Clinical	   Implications:	   Identification	  of	   myocardial	   viability	   following	   STEMI	   is	  one	   of	   challenging	   fields	   in	   modern	  interventional	   cardiology.	   Primary	  angioplasty	   is	   the	  recommended	  treatment	  of	  choice	  in	  centers	  provided	  with	  facilities	  to	   perform	   emergency	   coronary	  angiography	  within	   90	  minutes	   of	   hospital	  presentation.	   In	   centers	   without	   these	  facilities,	   or	   when	   primary	   angioplasty	  cannot	   be	   performed	   ‘on-­‐time’;	   however,	  thrombolytic	   therapy	   is	   still	   an	   alternative	  in	   patients	   presenting	   within	   the	  ‘appropriate’	   time	   window.	   In	   these	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patients,	  elective	  coronary	  angiography	  can	  still	  be	  performed	  ‘early’	  enough	  within	  the	  index	   hospitalization,	   provided	   that	   they	  prove	   to	   have	   ‘adequate’	   myocardial	  viability.	  Hence,	  an	  appealing	  strategy	   is	   to	  employ	   an	   ‘adequately	   safe’	   and	   accurate	  method	   for	   identifying	  myocardial	  viability	  early	  after	  STEMI	   in	  patients	  who	  received	  thrombolytic	   therapy.	   The	   results	   of	   the	  current	  study	  suggest	   that	   low-­‐dose	  DSE	   is	  a	  promising	  strategy	  for	  achieving	  this	  goal.	  	  
Study	  limitations:	  	  Our	   findings	   are	   based	   on	   a	   single	   center	  study	  with	  a	  relatively	  small	  sample	  size	  of	  the	   cohort,	   a	   fact	   that	  makes	   it	   difficult	   to	  generalize	   our	   results	   to	   all	   patients	  presenting	  with	  acute	  STEMI	  who	  received	  thrombolytic	   therapy.	   Multi-­‐center	   studies	  applying	   the	   same	  protocol	   and	   examining	  a	   larger	   number	   of	   patients	   are	   needed.	  Moreover,	   the	   follow-­‐up	   period	   of	   2-­‐3	  months	  might	  have	  been	  rather	  inadequate	  to	  allow	  recovery	  of	  some	  dys-­‐synergic	  but	  viable	   segments,	   thereby	   underestimating	  the	   specificity	   of	   low-­‐dose	   DSE	   for	  predicting	   contractile	   improvement	   after	  revascularization.	   Delayed	   recovery	   can	  further	   occur	   in	   a	   substantial	   number	   of	  segments	   up	   to	   a	   median	   of	   14	   months	  following	   revascularization,	   a	   fact	   that	  warrants	   repeated	  assessment	   after	   longer	  periods	   of	   follow-­‐up.	   Finally,	   follow-­‐up	  coronary	   angiography	   was	   not	   done,	  therefore,	  restenosis	  or	  re	  occlusion	  cannot	  be	   definitely	   excluded,	   something	   that	  would	   hazard	   the	   achieved	   functional	  improvement	   and	   again	   underestimate	  specificity.	   However,	   no	   patient	   reported	  any	   clinical	   events	   during	   the	   period	   from	  revascularization	   to	   follow-­‐up	  echocardiographic	  evaluation.	  	  	  
CONCLUSION	  	  Low-­‐dose	  DSE	   performed	   early	   in	   patients	  presenting	  with	   acute	   anterior	   STEMI	  who	  received	   thrombolytic	   therapy,	   is	   safe	  with	  
a	   high	   sensitivity	   but	   a	   modest	   specificity	  for	   predicting	   contractile	   improvement	  after	   revascularization,	   based	   on	   a	   per-­‐patient	   analysis.	  However,	   based	   on	   a	   per-­‐segment	   analysis,	   both	   sensitivity	   and	  specificity	  are	  high.	  Moreover,	  prediction	  of	  contractile	   improvement	   in	   hypokinetic	  segments	   was	   more	   sensitive	   but	   less	  specific	  than	  in	  akinetic	  ones.	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